Abstract
Objective: To analyze the prevalence of and factors associated with healthcare-associated infections (HAIs) in elderly patients admitted to Intensive Care Units (ICUs). Methods: A cross-sectional, descriptive, and analytical study conducted at a public hospital between 2019 and 2025. Microbiological cultures and antimicrobial susceptibility tests from adult patients (≥18 years old) with HAIs were analyzed. Analyses were performed using the Statistical Package for the Social Sciences® (SPSS), version 21.0, employing Pearson's chi-square test to evaluate associations between age groups and variables. Results: 59.3% of the patients were admitted to the ICU, with a mean of 1.51 infectious episodes per patient. Mortality was 64.4%, with the highest frequency of cases occurring in 2025 (26.6%; p=0.043). Among the elderly, males predominated (57.2%; p=0.005). Ventilator-associated pneumonia was the primary site of infection (63.9%; p=0.027), and tracheal aspirate was the most frequent specimen (70.9%; p<0.001). One to two HAIs per admission predominated (89.2%; p=0.344). Pseudomonas aeruginosa (24.0%), Klebsiella pneumoniae (23.7%), and Acinetobacter baumannii (23.0%; p<0.001) were the most prominent pathogens, with a predominance of non-fermenting Gram-negative bacilli and multidrug resistance. Conclusion: The study highlights the importance of epidemiological surveillance and the monitoring of risk factors to improve HAI prevention and control strategies.
References
1. AGÊNCIA NACIONAL DE VIGILÂNCIA SANITÁRIA (ANVISA). Boletins e relatórios das notificações de IRAS e outros eventos adversos (Internet). Brasília: ANVISA, s.d.Disponível em: https://www.gov.br/anvisa/pt-br/centraisdeconteudo/publicacoes/servicosdesaude/boletins-e-relatorios-das-notificacoes-de-iras-e-outros-eventos-adversos-1. Acessado em: 15denovembro de 2025.
2. ALENCAR SS, et al. Perfil microbiano e de resistência de aspirado traqueal em uma unidade de terapia intensiva e semi-intensiva de Macapá/AP. Temas em Saúde, 2021; 21(2): 51-66.
3. ANDRADE RC, et al. Polifarmácia, medicamentos potencialmente inapropriados e a vulnerabilidade de pessoas idosas. Rev Geriatr Gerontol, 2024; 27.
4. ANTONELLI A, et al. Healthcare-associated infections and antimicrobial use in acute care hospitals: a point prevalence survey in Lombardy, Italy, in 2022. BMC Infect Dis, 2024; 24(1): 632.
5. ASSIS SF, et al. Adverse events in critically ill patients: a cross-sectional study. Rev Esc Enferm USP, 2022; 56.
6. BAHIA. Secretaria da Saúde do Estado da Bahia. Diretoria de Vigilância Sanitária e Ambiental. Relatório anual de indicadores de infecções relacionadas à assistência à saúde (IRAS): 2020. Salvador: SESAB; 2021.
7. CARDOSO ALMEIDA AP, et al. Long-term occurrence of multiple antimicrobial drug resistant Klebsiella pneumoniae isolates harboring virulent potential in a tertiary hospital from Brazil. Braz J Microbiol, 2024; 55(3): 2313-2320.
8. CHAVES LSL, et al. Análise epidemiológica das infecções relacionadas à assistência à saúde em UTIs adultas nas regiões do Brasil entre 2020 e 2024. JRG Journal of Academic Studies, 2026; 9(20): e093441.
9. CHAVES M, et al. Perfil de resistência microbiana de enterobactérias envolvidas em infecções relacionadas à assistência à saúde. Revista Eletrônica Acervo Saúde, 2026; 23: e23379.
10. CHÁVEZ-TIERRA PA, et al. Prevalencia de infecciones recurrentes asociadas al cuidado de enfermería en pacientes críticos. Rev Arbitr Interdiscip Cienc Salud Salud Vida, 2025; 9(1): 303-314.
11. CRISTINA ML, et al. Epidemiology and prevention of healthcare-associated infections in geriatric patients: a narrative review. Int J Environ Res Public Health, 2021; 18(10): 5333.
12. DASH RK, et al. A five-year trend analysis of antibacterial resistance patterns among non-fermenting gram-negative bacilli: a retrospective study from the ICU settings of a tertiary care hospital. Cureus, 2024; 16(9).
13. DIAS L, et al. O papel do enfermeiro frente às ações de prevenção e controle de infecção hospitalar em unidade de terapia intensiva adulto: uma revisão integrativa. Rev Saúde Dom Alberto, 2023; 10(1): 45-68.
14. GOYANI P, et al. Immunosenescence: Aging and Immune System Decline. Vaccines (Basel), 2024; 12(12): 1314.
15. LANGLETE P, et al.Healthcare-associated COVID-19 infections and mortality. J Hosp Infect, 2025; 158: 61-68.
16. MAINA JW, et al. Carbapenem-resistant gram-negative bacterial infections and risk factors for acquisition in a Kenyan intensive care unit. BMC Infect Dis, 2024; 24(1): 522.
17. MESQUITA ASS, et al. Infecção relacionada à assistência à saúde em Unidade de Terapia Intensiva. Rev Eletr Acervo Saúde, 2023; 23(8): e13099.
18. OLIVEIRA RD, et al. Infecções relacionadas à assistência à saúde no Brasil: precisamos de mais do que colaboração. Rev Bras Ter Intensiva, 2022; 34(3): 313-315.
19. ODOOM A, DONKOR ES. Prevalence of Healthcare-Acquired Infections Among Adults in Intensive Care Units: A Systematic Review and Meta-Analysis. Health Sci Rep, 2025; 8(7).
20. SHEN L, et al. Catheter-associated urinary tract infection in hospitalized older patients: a case-control study. BMC Infect Dis, 2023; 23: 825.
21. SILVA TMF, et al. Infecções hospitalares associadas a bacilos gram-negativos não fermentadores em unidade de terapia intensiva: revisão narrativa. Revista Eletrônica Acervo Saúde, 2021; 13(3).
22. TOMAZINI BM, et al. Clinical impact of healthcare-associated infections in Brazilian ICUs: a multicenter prospective cohort. Crit Care, 2025; 29: 4.
23. VILLAR VCFL, et al. Segurança do paciente no cuidado hospitalar: uma revisão sobre a perspectiva do paciente. Cad Saúde Pública, 2020; 36(12).
